The PREFICM research consortium encloses a balanced number of clinical & technical groups, along with world-leading medical imaging companies, with the common goal of understand and asses the embolic risk of cardiac patients.


University of Washington

The research group of Prof. del Álamo in the Department of Mechanical Engineering of UW (previously in UCSD) is a world leader in the characterization of experimental and computational biomechanics, medical image post-processing and cardiovascular physiology assessment. The group is a worldwide reference in the characterization of intracardiac flows with clinical application.


Juán Carlos del Álamo

Universidad Nacional de Educación a Distancia

The Medical Physics research group of the Universidad Nacional de Educación a Distancia (UNED), lead by Prof. Antoranz, is formed by researchers with a long experience in research, applying physics to medicine, both using theoretical (i,e: mathematical models of tumor growth, or diastolic filling) or applied (medical imaging post processing or cardiac assist devices design) approaches.

José Carlos Antoranz

Universidad Politécnica de Madrid

The BITUPM group is a research group based on the Universidad Politécnica de Madrid. This group mainly works on different aspects related to biomedical images since 2000. Its main objective is the application of technological solutions to clinical or biological problems, especially with the objective of achieving an early diagnosis, surgical planning or therapeutic follow-up.

María Jesús Ledesma


The Instituto de Salud Carlos III (Institute of Health Carlos III) is the organization that manages the activities of the Health Research and Development Strategy (AES) under the State Plan for Scientific and Technical Research and Innovation 2017-2020.

The main objectives of the AES are to promote the health and well-being of the public, and to develop measures to prevent, diagnose and cure disease, and provide rehabilitation and palliative treatment.


The Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV) pools the work done by over 480 scientists from 40 excellence research groups spread almost all over Spain, with major presence in the National Health System, as well as in our main Healthcare Research Institutes, Universities and Research Centres.


Philips Iberica

Philips is a world leader in non-invasive medical imaging. In this project, this company will contribute to the development of new non-invasive imaging protocols and will facilitate the commercialization of the new methodology and its transfer to clinical practice.

General Electric Spain

General Electric España is part of the world’s biggest digital industrial company, transforming the industry with software-defined machines and connected, sensitive and predictive solutions. They will also contribute to the development of new non-invasive imaging protocols and will facilitate the commercialization of the new methodology and its transfer to clinical practice.


Medtronic is a global leader in medical technology, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes.